Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Feb 27, 2022; 14(2): 107-119
Published online Feb 27, 2022. doi: 10.4240/wjgs.v14.i2.107
Table 3 Effects of Csendes classification on surgical methods, operative time, bleeding volume, hospitalization time and cost (n = 66), (mean ± SD), (range, median)

Type I
Type II
Type III
Type IV
Statistics
n (%)42 (63.64%)14 (21.21%)10 (15.15%)0
Total bilirubin (μmol/L)≤ 282920-χ2 = 51.42; P = 0.000
28-5613113-
> 56017-
Surgical methodsLC29620-χ2 = 29.91; P = 0.000
LC convert to OC2320-
LC convert to OC + BDER + T-tube71,24383-
OC0120-
OC + BDER + T-tube41,2023-
Hospitalization time (d)12.8 ± 4.8; 6-25, 12.515.1 ± 6.2; 8-26, 13.515.9 ± 6.1; 8-31, 15-F = 1.981; P = 0.146
Treatment cost (CNY Yuan)23037 ± 5522; 13596-40815, 2196324916 ± 7146; 15108-36557, 2359330387 ± 6865; 17161-40568, 28624-F = 5.909; P = 0.004
Operative time (minutes)154.4 ± 91.1; 50-395, 122.5230.4 ± 133.7; 80-480, 175219.0 ± 122.2; 95-520, 177.5-F = 3.486; P = 0.037
Bleeding volume (mL)96.6 ± 81.5; 20-340, 60191.4 ± 123.3; 30-390, 180163.5 ± 114.3; 25-400, 140-F = 5.919; P = 0.004